SclerFIX-IP
Asset
Amniotic membrane interposition graft for joint cushioning and regeneration
- Stage
- Phase 2
- Modality
- Other
- Target
- Inflammation
- 1
- Indication
- 2
- Trials
- 1
- Developer
Indications
1Osteoarthritis hand
Phase 2, Terminated, NCT06034262, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials2
- Evidence for its targets1
Every asset’s record: target, stage, trials and the evidence behind it.